Anti-Diabetic

Check out our products belonging to the Anti-Diabetic - Therapeutic Category.

LIPTA-M

LIPTA-M

Generic Name

Linagliptin,Metformin

Composition

Metformin HCl IP 500/850/1000 mg Linagliptin 2.5 mg Tablets

Dosage Type

Sustained Release Tablet

Pack Size

10x10

Strength

500/850/1000mg

MRP

Rs. 14/16/17

LIPTA-M is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus when treatment with both linagliptin and metformin is appropriate.

Recommended Dosing

  • The dosage of LIPTA-M should be individualized on the basis of both effectiveness and tolerability, while not exceeding the maximum recommended dose of 2.5 mg linagliptin/1000 mg metformin hydrochloride twice daily. LIPTA-M should be given twice daily with meals. Dose escalation should be gradual to reduce the gastrointestinal (GI) side effects associated with metformin use. For available dosage forms and strengths

Recommended starting dose:

  • In patients currently not treated with metformin, initiate treatment with 2.5 mg linagliptin/500 mg metformin hydrochloride twice daily
  • In patients already treated with metformin, start with 2.5 mg linagliptin and the current dose of metformin taken at each of the two daily meals (e.g., a patient on metformin 1000 mg twice daily would be started on 2.5 mg linagliptin/1000 mg metformin hydrochloride twice daily with meals).
  • Patients already treated with linagliptin and metformin individual components may be switched to LIPTA-M containing the same doses of each component.

LIPTA-M is contraindicated in patients with:

  • Severe renal impairment (eGFR below 30 mL/min/1.73 m2)
  • Acute or chronic metabolic acidosis, including diabetic ketoacidosis. Diabetic ketoacidosis should be treated with insulin
  • A history of hypersensitivity reaction to linagliptin, such as anaphylaxis, angioedema, exfoliative skin conditions, urticaria, or bronchial hyperreactivity
  • Hypersensitivity to metformin
  • Pancreatitis
  • Lactic acidosis
  • Children and adolescents
  • Alcohol
  • Pregnancy and breast-feeding
  • Driving and using machines
  • Diarrhea
  • URTI
  • Headache
  • Nasopharyngitis
  • Hypoglycemia
  • Pancreatitis
  • Hypersensitivity reactions
  • Severe and disabling arthralgia
  • Rare: lactic acidosis (may be fatal).
  • Do not store above 25°C (77°F). Protect from moisture.
  • Store in a cool and dry place away from sunlight.

LIPTA-M 500:  10×10’s

LIPTA-M 850:  10×10’s

LIPTA-M 1000: 10×10’s